2022
DOI: 10.22207/jpam.16.2.66
|View full text |Cite
|
Sign up to set email alerts
|

Isolation and Identification of Pathogenic Bacteria Causing Otitis Media in Misan Governorate

Abstract: This study examined 150 ear swab samples from patients with otitis media who consulted at Al-Sadr Teaching Hospital from January to April 2021 in Misan, Iraq. The participants were aged 14–50 years, among which the infection rate was highest in participants aged 14–22 years and lowest in those aged 40–50 years. Subsequently, bacterial isolates were identified based on their morphology in various culture media and using biochemical tests. Six bacterial species were identified, namely Pseudomonas aeruginosa, Sta… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 47 publications
0
2
0
Order By: Relevance
“…[21][22][23][24][25] However, other studies have reported that S. aureus was the most prevalent pathogen. 3,26,27 Recently, Udden et al 28 revealed that Proteus spp. are common pathogens that caused ear infections.…”
Section: Discussionmentioning
confidence: 99%
“…[21][22][23][24][25] However, other studies have reported that S. aureus was the most prevalent pathogen. 3,26,27 Recently, Udden et al 28 revealed that Proteus spp. are common pathogens that caused ear infections.…”
Section: Discussionmentioning
confidence: 99%
“…In this study, we investigate the antioxidant, healing, and direct antimicrobial properties of ARAG. To ensure clinical relevance to burn victims, we tested ARAG’s ability to inhibit the growth of bacteria commonly found to colonize burns: K. pneumoniae , P. vulgaris , P. aeruginosa , and S. aureus [ 11 , 12 , 19 , 20 ]. We then compared the efficiency of ARAG to ionized silver to test the in vitro efficacy of ARAG against a simulation of the current standard of care, Mepilex Ag.…”
Section: Introductionmentioning
confidence: 99%